API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
10
PharmaCompass offers a list of Diphenhydramine Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diphenhydramine Citrate manufacturer or Diphenhydramine Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diphenhydramine Citrate manufacturer or Diphenhydramine Citrate supplier.
PharmaCompass also assists you with knowing the Diphenhydramine Citrate API Price utilized in the formulation of products. Diphenhydramine Citrate API Price is not always fixed or binding as the Diphenhydramine Citrate Price is obtained through a variety of data sources. The Diphenhydramine Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diphenhydramine Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diphenhydramine Citrate, including repackagers and relabelers. The FDA regulates Diphenhydramine Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diphenhydramine Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diphenhydramine Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diphenhydramine Citrate supplier is an individual or a company that provides Diphenhydramine Citrate active pharmaceutical ingredient (API) or Diphenhydramine Citrate finished formulations upon request. The Diphenhydramine Citrate suppliers may include Diphenhydramine Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Diphenhydramine Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diphenhydramine Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Diphenhydramine Citrate active pharmaceutical ingredient (API) in detail. Different forms of Diphenhydramine Citrate DMFs exist exist since differing nations have different regulations, such as Diphenhydramine Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diphenhydramine Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Diphenhydramine Citrate USDMF includes data on Diphenhydramine Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diphenhydramine Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diphenhydramine Citrate suppliers with USDMF on PharmaCompass.
A Diphenhydramine Citrate written confirmation (Diphenhydramine Citrate WC) is an official document issued by a regulatory agency to a Diphenhydramine Citrate manufacturer, verifying that the manufacturing facility of a Diphenhydramine Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Diphenhydramine Citrate APIs or Diphenhydramine Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Diphenhydramine Citrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Diphenhydramine Citrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diphenhydramine Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diphenhydramine Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diphenhydramine Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diphenhydramine Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diphenhydramine Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diphenhydramine Citrate suppliers with NDC on PharmaCompass.
Diphenhydramine Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diphenhydramine Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diphenhydramine Citrate GMP manufacturer or Diphenhydramine Citrate GMP API supplier for your needs.
A Diphenhydramine Citrate CoA (Certificate of Analysis) is a formal document that attests to Diphenhydramine Citrate's compliance with Diphenhydramine Citrate specifications and serves as a tool for batch-level quality control.
Diphenhydramine Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Diphenhydramine Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diphenhydramine Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Diphenhydramine Citrate EP), Diphenhydramine Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diphenhydramine Citrate USP).